Indication
Parapsoriasis
1 clinical trial
3 products
Clinical trial
A Phase 4, Multicenter, Randomized, Placebo-controlled, Double-blind, Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate Plaque PsoriasisStatus: Completed, Estimated PCD: 2016-02-12
Product
PlaceboProduct
ApremilastProduct
Placebo-Apremilast